Related Experiment Video
Updated: Jul 12, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
Candida parapsilosis endocarditis: a comparative review of the literature
Abstract:
Fungal endocarditis (FE) is an uncommon disease, and while accounting for only 1.3-6% of all cases of infectious endocarditis, it carries a high mortality risk. Although Candida albicans represents the main etiology of FE, C. parapsilosis is the most common non-albicans species. We report the case of a 32-year-old man with a history of prior intravenous drug (IVD) use hospitalized with endocarditis due to C. parapsilosis and review all 71 additional cases documented in the literature. A retrospective analysis of the 72 C. parapsilosis cases compared to 52 recently reviewed cases of C. albicans endocarditis was conducted to identify organism-specific clinical peculiarities. The most common predisposing factor for C. parapsilosis endocarditis (41/72; 57.4%) involved prosthetic valves followed by IVD use (12/72; 20%). Peripheral embolic and/or hemorrhagic events occurred in 28/64 (43.8%) patients, mostly in cerebral and lower limb territories. Overall mortality was 41.7%. Combined surgical and clinical treatment was associated with a lower mortality. Few patients received the newer antifungal agents, and it would appear that more experience is required for their use in the treatment of C. parapsilosis endocarditis.
Insights
Fungal endocarditis (FE) due to Candida parapsilosis is rare but deadly. Prosthetic valves and IV drug use are key risks, with high rates of embolic events and mortality, underscoring treatment challenges.
Area of Science:
- Mycology
- Infectious Diseases
- Cardiology
Background:
- Fungal endocarditis (FE) is a rare but severe condition, accounting for 1.3-6% of infectious endocarditis cases.
- Candida albicans is the primary cause of FE, but Candida parapsilosis is the most frequent non-albicans species implicated.
Observation:
- This study reports a case of C. parapsilosis endocarditis in a 32-year-old male with a history of intravenous drug use.
- A retrospective analysis reviewed 72 cases of C. parapsilosis endocarditis, comparing them with 52 cases of C. albicans endocarditis.
Findings:
- The most common predisposing factors for C. parapsilosis endocarditis were prosthetic valves (57.4%) and intravenous drug use (20%).
- Peripheral embolic or hemorrhagic events occurred in 43.8% of patients, frequently affecting the cerebral and lower limb vasculature.
- The overall mortality rate was 41.7%, with combined surgical and clinical treatment showing a trend towards lower mortality.
Implications:
- C. parapsilosis endocarditis presents unique clinical features and risk factors compared to C. albicans.
- Further research is needed to establish optimal treatment strategies, including the role of newer antifungal agents, for C. parapsilosis endocarditis.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Candidiasis
Pericarditis I: Introduction

